Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
melphalan (alkeran) (2021)
daratumumab (darzalex) (2 trials)
dexamethasone (6 trials)
melphalan (alkeran) (9 trials)
pomalidomide (pomalyst) (1 trial)
urea (3 trials)
bortezomib (velcade) (1 trial)
opd5 (1 trial)
Amyloidosis (Phase 2)
Immunoglobulin Light-chain Amyloidosis (Phase 2)
Multiple Myeloma (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Renal Insufficiency (Phase 2)
Trials (10 total)
Trial APIs (7 total)